The US Food and Drug Administration (FDA) approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.
We may tend to think of our health-care system as a national program. In reality, the states and territories are responsible for delivering health-care services. That means local authorities are in charge of setting up health programs and sometimes opinions vary about what’s the best approach. As a result, cancer screening can differ from one…
What to know before you go to your annual gynecology appointment
“The good news is A, the HPV vaccine is likely to make a big impact on women, and B, the screening frequency is probably going to go down in the near future,”
Cervical cancer is often detected through Pap smears; after all, there is a correlation between human papillomavirus (HPV) infections and cervical cancer. But now, a study shows that a new HPV test showed promising results in finding precancerous cervical changes. And, not only that, but the test was more accurate than Pap smears at doing…
When it comes to cervical cancer screening, most women receive a cytology-based Papanicolau (Pap) smear, where cells are scraped from the back of the cervix. However, human papillomavirus (HPV)-based testing may be a more accurate way of testing for cervical cancer, new study results suggest.1 Despite the widespread use of cervical cancer screening with a…
Histologically, CC can be characterized by two different sub-categories i.e. (i) invasive squamous cell carcinomas (ISCC) which are frequent and covers 85–90% of CC cases (ii) adenocarcinomas (ADC) which are relatively rare and comprises only 10–15% cases. The CC develops progression of precancerous lesions; called cervical intraepithelial neoplasia (CIN) grade 1–3 or squamous intraepithelial lesion (SIL).
In women with high-grade cervical intraepithelial neoplasia (CIN 2,3), positive margins on the cone biopsy specimen are predictive of recurrent high-grade or invasive disease (CIN 2+). However, a recent meta-analysis found that a positive test for high-risk human papillomaviruses (HPV) after excision was a more accurate indicator of treatment failure (sensitivity 91 percent for HPV…
A leading expert in cancer immunology predicts that cervical cancer can be eliminated over a 20-year period if a comprehensive vaccination programme is implemented.
The test was officially introduced in December 2017, and revolutionises testing for cervical cancer in Australia. Many women might be pleased to hear that the dreaded discomfort of the two-yearly Pap smear has been replaced by a new and improved five-yearly cervical screening test.